The Real Drug War: Beware, Drugmakers. with Senior Citizens Struggling to Afford Their Prescriptions, Soaring Pill Prices Are Turning into an Explosive Issue

Newsweek, May 8, 2000 | Go to article overview
Save to active project

The Real Drug War: Beware, Drugmakers. with Senior Citizens Struggling to Afford Their Prescriptions, Soaring Pill Prices Are Turning into an Explosive Issue


Living in senior housing on $1,000 a month, plagued by arthritis and severe stomach problems, Viola Quirion has been forced to make some hard choices. "I had to skip my drugs and I had a lot of pain," says the 73-year-old resident of Waterville, Maine, who worked for 40 years in a shirt factory. "I tried to skip some meals, I bought the cheapest food I could." Quirion is a Medicare recipient with no prescription-drug coverage--the federal medical insurance program doesn't cover outpatient prescription drug costs for anybody. She pays more than $200 a month for the medicine she needs: Prilosec for her stomach and Relafen for her arthritis. "When I skip the Relafen, my inflammation comes back," she says. "And if I skip the Prilosec, I can't digest my food." Twice last year, she traveled by bus with other Maine seniors to Montreal, four hours from her home, where she saved almost $200 on a three-month supply of medicine. "It's pretty rough," she says. "We're a bunch of senior citizens with canes and crutches and oxygen."

Except for the trips to Canada, a random advantage of living in a border state, Quirion's story is hardly unique. She could be the poster patient for what has emerged as one of the election year's most explosive political issues. Quirion is one of an estimated 13 million elderly Americans with no prescription-drug coverage. This doesn't just affect poor people: many middle-class seniors without additional private insurance struggle to pay for the drugs they need. To get by, some occasionally go without their medicine. Some break pills in half. Others take fewer pills than their doctors prescribe. All are victims of what critics of the drug industry call price discrimination. Even Hollywood recognizes the drama of the issue. On "ER" last week an elderly woman, in a potentially fatal move, took her husband's blood pressure medicine because she couldn't afford her own.

Drug companies are scrambling to make sure that the mounting crisis won't be fatal to their profits, currently among the highest in American industry. The clash pits the well-connected pharmaceutical companies, with projected U.S. sales this year of more than $100 billion, against an equally formidable foe, the influential senior-citizens lobby. For politicians, the issue and the photo ops are irresistible. Last week, Al Gore was snapped helping an elderly woman buy her medicine at a pharmacy. George Bush favors a plan to help low-income seniors buy coverage from private insurers. Up in Maine, legislators are debating a bill that could make it the first state in the nation to limit what drug companies charge for prescription drugs. The landmark legislation could be signed as soon as next week, and similar bills are in the works in states from New York to Arizona.

The stretched seniors are pushing to correct a basic imbalance in the drug marketplace. Bulk drug buyers like HMOs and big health insurers are able to negotiate with pharmaceutical makers for discounts and rebates of up to 40 percent. Meanwhile, foreign countries, such as Canada and Mexico, impose price controls to help consumers. But U.S. seniors without drug coverage end up paying full price for their prescription drugs. Studies have shown that they regularly fork over twice as much as those who get the best deals, and in some cases their costs are four times higher. The prices of the 50 drugs seniors use most increased last year at nearly double the rate of inflation, according to a new study. "The most profitable industry in the country is charging the highest prices in the world to the Americans who can least afford it," says Democratic Rep. Tom Allen of Maine, who is pushing a bill to force drug manufacturers to give all 39 million people on Medicare the same steep discounts the Department of Defense and other government agencies get.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

The Real Drug War: Beware, Drugmakers. with Senior Citizens Struggling to Afford Their Prescriptions, Soaring Pill Prices Are Turning into an Explosive Issue
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?